These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Prevalence, specificity and determinants of lipid-interacting PDZ domains from an in-cell screen and in vitro binding experiments. Ivarsson Y; Wawrzyniak AM; Kashyap R; Polanowska J; Betzi S; Lembo F; Vermeiren E; Chiheb D; Lenfant N; Morelli X; Borg JP; Reboul J; Zimmermann P PLoS One; 2013; 8(2):e54581. PubMed ID: 23390500 [TBL] [Abstract][Full Text] [Related]
12. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis. Yang JB; McCarthy JB Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924 [TBL] [Abstract][Full Text] [Related]
13. Degenerate specificity of PDZ domains from RhoA-specific nucleotide exchange factors PDZRhoGEF and LARG. Smietana K; Kasztura M; Paduch M; Derewenda U; Derewenda ZS; Otlewski J Acta Biochim Pol; 2008; 55(2):269-80. PubMed ID: 18542831 [TBL] [Abstract][Full Text] [Related]
14. Organization and dynamics of PDZ-domain-related supramodules in the postsynaptic density. Feng W; Zhang M Nat Rev Neurosci; 2009 Feb; 10(2):87-99. PubMed ID: 19153575 [TBL] [Abstract][Full Text] [Related]
15. Structure and function of PICK1. Xu J; Xia J Neurosignals; 2006-2007; 15(4):190-201. PubMed ID: 17215589 [TBL] [Abstract][Full Text] [Related]
16. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Meyer G; Varoqueaux F; Neeb A; Oschlies M; Brose N Neuropharmacology; 2004 Oct; 47(5):724-33. PubMed ID: 15458844 [TBL] [Abstract][Full Text] [Related]
17. Structural insights into the PIP2 recognition by syntenin-1 PDZ domain. Sugi T; Oyama T; Morikawa K; Jingami H Biochem Biophys Res Commun; 2008 Feb; 366(2):373-8. PubMed ID: 18062914 [TBL] [Abstract][Full Text] [Related]